Clinical Trial Update: Regression of Myocardial Steatosis by Nebivolol [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial of nebivolol reports regression of myocardial steatosis in participants with cardiac steatosis. The findings are preliminary, based on a …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Steatosis

Drugs mentioned

• Nebivolol (Nebivolol)

Snippet

Sponsor: Lidia Szczepaniak | Conditions: Cardiac Steatosis and Lipotoxicity | EARLY_Phase 1 | Status: COMPLETED